EPP 7: Upscale Malaysia’s IVD Industry - Mediven & Olipro

  • GNI by 2020 (mil)
  • Projected jobs by 2020

EPP 7: Upscale Malaysia’s In-Vitro Diagnostic (IVD) Industry

In 2014, Olipro Biotechnology, a Bionexus status company that manufactures World Health Organisation-standard test kits in Malaysia also joined this EPP. The company is undertaking a project to manufacture its HIV 1/2 Rapid Test Kit which screens and detects HIV 1 & 2, and the Olipro BloodChek LF Kit that detects transfusion-transmissible infections during blood donations or screenings. The project is expected to contribute RM6.83 million in GNI, RM900,000 in investment and 38 new jobs.

  • Investment (mil)


  • Mediven continues to work with the respective authorities to ensure its medical devices comply with the necessary standards for the local and export markets.
  • Olipro is constructing a new manufacturing facility and in 2014, launched six new products. It has also expanded its market to Indonesia and Brunei.
Photo Gallery

Work In Progress
Economic Transformation Programme
The ETP Transformation Story
The Economic Transformation Programme (ETP) is a comprehensive effort that will transform Malaysia into a high-income nation by 2020.
Copyright © 2013 Performance Management & Delivery Unit (PEMANDU)